ERNEXA THERAPEUTICS INC (ERNA) Stock Income Statement
USA - NASDAQ:ERNA - US1140823089 - Common Stock
1.35 USD
+0.07 (+5.47%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 488.00K | 582.00K | 68.00K | 0.00 | 0.00 | |||
| Cost Of Goods | -60.00K | 96.00K | 236.00K | N/A | N/A | |||
| Gross Profit | 548.00K | 486.00K | -168.00K | N/A | N/A | |||
| Operating Expenses | 11.99M | 17.74M | 20.51M | 27.23M | 27.43M | |||
| Research and Development | 4.60M | 4.60M | 5.92M | 10.39M | 12.71M | |||
| Selling, General, and Administrative Expenses | 7.71M | 13.13M | 14.59M | 16.84M | 14.72M | |||
| Operating Income | -11.93M | -17.25M | -20.68M | -27.23M | -27.43M | |||
| Interest Income/Expense | -5.36M | -6.95M | -535.00K | -970.00K | -70.00K | |||
| Other Income/Expense | -5.69M | 550.00K | -1.00K | 9.65M | 660.00K | |||
| Non Recurring Items | N/A | -20.86M | -460.00K | -5.99M | -85.99M | |||
| Income Before Taxes | -44.08M | -44.51M | -21.67M | -24.53M | -122.48M | |||
| Income Tax | 32.00K | 30.00K | -3.00K | 50.00K | 60.00K | |||
| Net Income | -44.12M | -44.55M | -21.68M | -24.60M | -122.56M | |||
| EBITDA | -11.83M | -17.11M | -20.59M | -27.07M | -27.31M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -80.03 | -48.97 | -61.21 | -120.94 | -848.98 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 112.30% | 83.51% | -247.06% | N/A | N/A | |||
| Profit Margin | -9040.16% | -7655.50% | -31888.24% | N/A | N/A | |||
| Operating Profit Margin | -2444.26% | -2963.92% | -30404.41% | N/A | N/A | |||
All data in USD